News
Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, testified at a hearing on the accessibility of generic drugs. She talked about progress being made on reducing ...
Once process implementation is complete, clinical sample manufacturing and analytical work will commence in Vektor 's EU GMP laboratory and manufacturing facility based in Baden-Württemberg, Germany.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results